Biofilm formation by and antifungal susceptibility of Candida isolates from urine

Applied and Environmental Microbiology

Volumn 73, Issue 6, 2007, Pages 1697-1703

  Jain, N ^a   Kohli, R ^a   Cook, E ^a   Gialanella, P ^b   Chang, T ^b   Fries, B C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORRELATION METHODS; DISEASES; FUNGI; GROWTH KINETICS; PATIENT MONITORING;

CANDIDA ISOLATES; FLUCONAZOLES; RETROSPECTIVE CHARTS;

BIOFILMS;

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; BIOFILM; FUNGAL DISEASE; FUNGUS; RISK FACTOR; URINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; FUNGAL STRAIN; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RISK FACTOR; TREATMENT FAILURE; URINALYSIS;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CULTURE MEDIA; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS; URINE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS;

EID: 33947359453     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.02439-06     Document Type: Article

References (45)

1. Al-Fattaní, M. A., and L. J. Douglas. 2004. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 48:3291-3297.
2. Amer, F. A., H. A. Mohtady, I. M. el-Behedy, S. Khalil, Y. A. el-Hendy, E. A. e-Gindy, and H. E. Salem. 2004. Bacteria of nosocomial urinary tract infections at a university hospital in Egypt: identification and associated risk factors. Infect. Control Hosp. Epidemiol. 25:895-897.
3. Andes, D., J. Nett, P. Oschel, R. Albrecht, K. Marchillo, and A. Pitula. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031.
4. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
5. Blasí, E., A. Brozzetti, D. Francísa, R. Neglia, G. Cardinali, F. Bistoni, V. Vidotto, and F. Baldelli. 2001. Evidence of microevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis. Eur. J. Clin. Microbiol. Infect. Dis. 20:535-543.
6. D'Antonio, D., F. Romano, E. Pontierí, G. Fíoritoni, C. Caraccíolo, S. Bianchíní, P. Olioso, T. Staníscia, R. Sierra, S. Boccia, A. Vetuschi, G. Federíco, E. Gaudio, and G. Carruba. 2002. Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation. J. Clin. Microbiol. 40:1381-1386.
7. Di Martino, P., A. Meneau, R. Phillips, N. Orange, and C. Hulen. 2002. Isolation of an Escherichia coil strain mutant unable to form biofilm on polystyrene and to adhere to human pneumocyte cells: involvement of tryptophanase. Can. J. Microbiol. 48:132-137.
8. Dodgson, A. R., C. Pujol, D. W. Denning, D. R. Soll, and A. J. Fox. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41:5709-5717.
9. Domergue, R., I. Castano, A. De Las Penas, M. Zupancic, V. Lockatell, J. R. Hebel, D. Johnson, and B. P. Cormack. 2005. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308:866-870.
10. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
11. El-Azizi, M. A., S. E. Starks, and N. Khardori. 2004. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J. Appl. Microbiol. 96:1067-1073.
12. Fisher, J. F., K. Woeltje, A. Espinel-Ingroff, J. Stanfield, and J. T. DiPiro. 2003. Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience. Clin. Microbiol. Infect. 9:1024-1027.
13. Franzot, S. P., J. Mukherjee, R. Cherniak, L. C. Chen, J. S. Hamdan, and A. Casadevall. 1998. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect. Immun. 66:89-97.
14. Fries, B. C., and A. Casadevall. 1998. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J. Infect. Dis. 178:1761-1766.
15. Griffith, D. P., D. M. Musher, and C. Itin. 1976. Urease: the primary cause of infection-induced urinary stones. Investig. Urol. 13:346-350.
16. Guze, L., and L. Harley. 1957. Fungus infections of the urinary tract. Yale J. Biol. Med. 1957:292-305.
17. Harris, A. D., J. Castro, D. C. Sheppard, Y. Carmeli, and M. H. Samore. 1999. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin. Infect. Dis. 29:926-928.
18. Jin, Y., L. P. Samaranayake, Y. Samaranayake, and H. K. Yip. 2004. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch. Oral Biol. 49:789-798.
19. Kauffman, C. A. 2005. Candiduria. Clin. Infect. Dis. 41(Suppl. 6):S371-S376.
20. Kauffman, C. A., J. A. Vazquez, J. D. Sobel, H. A. Gallis, D. S. McKinsey, A. W. Karchmer, A. M. Sugar, P. K. Sharkey, G. J. Wise, R. Mangi, A. Mosher, J. Y. Lee, W. E. Dismukes, et al. 2000. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin. Infect. Dis. 30:14-18.
21. Kuhn, D. M., M. Balkis, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2003. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J. Clin. Microbiol. 41:506-508.
22. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
23. Kumamoto, C. A. 2002. Candida biofilms. Curr. Opin. Microbiol. 5:608-611.
24. Kumamoto, C. A., and M. D. Vinces. 2005. Alternative Candida albicans lifestyles: growth on surfaces. Annu. Rev. Microbiol. 59:113-133.
25. Kumar, C. P., and T. Menon. 2006. Biofilm production by clinical isolates of Candida species. Med. Mycol. 44:99-101.
26. Li, X., Z. Yan, and J. Xu. 2003. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149:353-362.
27. Mukherjee, P. K., G. Zhou, R. Munyon, and M. A. Ghannoum. 2005. Candida biofilm: a well-designed protected environment. Med. Mycol. 43:191-208.
28. Pfaller, M. A., J. Rhine-Chalberg, A. L. Barry, and J. H. Rex. 1995. Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions. Clin. Infect. Dis. 21: 1507-1509.
29. Ramage, G., S. Bachmann, T. F. Patterson, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49:973-980.
30. Ramage, G., and J. L. Lopez-Ribot. 2005. Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol. Med. 118:71-79.
31. Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
32. Ramage, G., K. Vandewalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170.
33. Richards, M. J., J. R. Edwards, D. H. Culver, R. P. Gaynes, et al. 1999. Nosocomial infections in medical intensive care units in the United States. Crit. Care Med. 27:887-892.
34. Richards, M. J., J. R. Edwards, D. H. Culver, R. P. Gaynes, et al. 1999. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 103:e39.
35. Safdar, N., W. R. Slattery, V. Knasinski, R. E. Gangnon, Z. Li, J. D. Pirsch, and D. Andes. 2005. Predictors and outcomes of candiduria in renal transplant recipients. Clin. Infect. Dis. 40:1413-1421.
36. Samaranayake, Y. H., L. P. Samaranayake, J. Y. Yau, R. S. Dassanayake, T. K. Li, and S. Anil. 2003. Phenotypic diversity of oral C. albicans isolated on single and sequential visits in an HIV-infected Chinese cohort. APMIS 111:329-337.
37. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:72S-75S.
38. Shin, J. H., S. J. Kee, M. G. Shin, S. H. Kim, D. H. Shin, S. K. Lee, S. P. Suh, and D. W. Ryang. 2002. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 40:1244-1248.
39. Shuford, J. A., K. E. Piper, J. M. Steckelberg, and R. Patel. 30 November 2006, posting date. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn. Microbiol. Infect. Dis. doi:10.1016/j.diagmicrobio.2006.09.004.
40. Shuford, J. A., M. S. Rouse, K. E. Piper, J. M. Steckelberg, and R. Patel. 2006. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J. Infect. Dis. 194:710-713.
41. Sobel, J. D. 1999. Management of asymptomatic candiduria. Int. J. Antimicrob. Agents 11:285-288.
42. Sobel, J. D., C. A. Kauffman, D. McKinsey, M. Zervos, J. A. Vazquez, A. W. Karchmer, J. Lee, C. Thomas, H. Panzer, W. E. Dismukes, et al. 2000. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin. Infect. Dis. 30:19-24.
43. Sobel, J. D., and T. Lundstrom. 2001. Management of candiduria. Curr. Urol. Rep. 2:321-325.
44. Tavanti, A., N. A. Gow, S. Senesi, M. C. Maiden, and F. C. Odds. 2003. Optimization and validation of multilocus sequence typing for Candida albicans. J. Clin. Microbiol. 41:3765-3776.
45. Tortorano, A. M., A. Prigitano, E. Biraghi, and M. A. Viviani. 2005. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J. Antimicrob. Chemother. 56:777-779.